Quorum Sensing-Based Interaction Network Construction for Drugs, Microbes, and Diseases
Shengbo Wu,Shujuan Yang,Man-Ling Wang,Hao Wu,Chunjiang Liu,Yanni Li,Fei Guo,Jianjun Qiao
DOI: https://doi.org/10.21203/rs.3.rs-845581/v1
2021-01-01
Abstract:Background:Various diseases and health are closely related to different gut microbes, which own complex interactions with diverse drugs, while the detailed targets for drug-microbe interactions are still limited and investigated separately. Quorum sensing (QS), a potential target for dealing with drug resistant, are yet to be further explored systematically for drug-microbe interactions. Furthermore, many existing studies have reported diverse casual associations among drugs, gut microbes, and diseases, which call for a systematic framework and repository to reveal their intricate interactions.Results:In this study, interactions between microbes and more than 8000 drugs have been systematically studied targeting on microbial quorum sensing receptors (LuxR, LasR, TraR, CviR, PqsR, QscR, YenR, SdiA, LsrB, LuxP, CckA) combined docking-based virtual screening technique and in vitro experimental validation. We have also illustrated the potential drug-microbe interaction network based on the predicted docking-based results to to have a more comprehensive illustration for the drug-microbe interactions, along with obtaining 14 possible potential broad-spectrum drugs for all of the 11 QS receptors. Furthermore, we have constructed a systematic framework including various connections for drugs, receptors, microbes, and diseases to form a comprehensive repository and network, which can give the QS-based underlying mechanisms for the reported causal associations between drugs and microbes at the phenotypic level. The framework, repository, and network will promote the understanding on personalized medicine and developing potential therapies for diverse diseases. Conclusions: Taken together, we curated and predicted various interactions carefully for drugs, receptors, microbes, and diseases to form a comprehensive framework, repository, and network for QS-based drug-microbe-disease interactions. This work contributes to the paradigm for the construction of the more comprehensive molecule-receptor-microbe-disease interaction network for human health that may form one of the key knowledge maps of the precision medicine in the future.